Vulvar Carcinoma Presenting during Pregnancy, Associated with Recurrent Bone Marrow Hypoplasia: A Case Report and Literature Review

Bakour, Shagaf H.; Jaleel, Henna; Weaver, Judith B.; Kehoe, Sean; Radcliffe, K W

doi:10.1006/gyno.2002.6802

Cited by 24 publications

(41 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of squamous cell carcinoma of the vulva in younger women has been increasing, particularly in association with human papillomavirus (HPV). Only 25 previous cases in pregnancy have been reported (Heller et al, 2000;Bakour et al, 2002). We present an unusual case in that the patient concealed her disease from her medical attendants, so the first diagnosis was made at induction of labour.…”

Section: Introductionmentioning

confidence: 69%

Carcinoma of the vulva in pregnancy

Ghosh

Banfield

2004

Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 69%

Carcinoma of the vulva in pregnancy

Ghosh

Banfield

2004

Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

“…45,50 In the successfully treated vulval cancer patient there seems to be no contraindication to future pregnancy. 36,39,40,50 Both vaginal delivery 6,31 and Caesarean section 6,49 have been reported. We found a 62% Caesarean section rate in those having had prior treatment for vulval cancer, where four (50%) were performed in view of significant vulval scarring.…”

Section: Discussionmentioning

confidence: 99%

“…36 The majority of women presented in the second (n=9, 43%) or third trimester (n=9, 43%), with only three women (14%) presenting in the post-natal period. 9,37,38 The presence of a vulval mass (n=11, 52%) was the most common presenting complaint (n=5, 23%; vulval pruritus n=1, 5%; vulval pain 5%; vulval wart 5% incidental finding at delivery).…”

Section: Vulval Carcinoma In Pregnancymentioning

confidence: 98%

Squamous Cell Vulval Carcinoma and Pregnancy — A Review

Palmer¹,

Vatish²,

Tidy³

2010

European Oncology &Amp; Haematology

View full text Add to dashboard Cite

Carcinoma of the vulva accounts for 4% of all female genital tract malignancies. 1 The incidence in the UK is two per 100,000 female population. 2 Vulval cancer is rare in young women with rates of more than one per 100,000 among women aged 25-44 years in the UK. 2 In the US, 15% of vulval cancers are reported to occur in women <50 years of age. 3,4 Prior studies have reported an incidence of 3.3% in women <35 years old, 5 2.3% in women <40 years old and 6.1%in women <45 years old. 6In recent years, an increased incidence of vulval cancer in younger women has been observed. Reports of either vulval carcinoma presenting during pregnancy, 25,[27][28][29] or of pregnancy following treatment for vulval cancer, are rare [29][30][31] because the majority of women with the condition are perimenopausal with completed families, post-menopausal or rendered infertile or of reduced fertility following treatment with radiotherapy and chemotherapy. 31 With the increasing incidence of HPV, VIN and HIV, and a concomitant increase in the incidence of vulval carcinoma in younger women, we are progressively more likely to encounter patients with either vulval carcinoma in pregnancy or pregnancy following treatment for vulval cancer. Given the paucity of available information to assist in managing these patients, and the increased likelihood of seeing this condition, a review of the management strategies in squamous cell vulval cancer associated with pregnancy is timely. MethodWe performed a computerised search (MEDLINE ® /embase ® ) to Squamous Cell Vulval Carcinoma and Pregnancy -A Review AbstractMaternal vulval carcinoma and pregnancy following vulval cancer are rare. However, vulval carcinoma in younger women is increasing, thus we are progressively more likely to encounter patients with either vulval carcinoma in pregnancy, or pregnancy following treatment for vulval cancer. Given the paucity of available information we performed a literature review considering the strategies employed in the management of these women. A computerised search (MEDLINE ® /embase ® ) was performed to identify all registered articles pertaining to squamous cell vulval carcinoma diagnosed or treated in pregnancy, and all cases of pregnancy following treatment for vulval cancer. In addition, cross-references of all selected articles were checked. Twenty-four reports were identified in the literature. In total, 21 cases of vulval carcinoma in pregnancy and 13 cases of pregnancy following vulval cancer were considered. Reports in the literature of vulval cancer associated with pregnancy span a time period of over 65 years making the production of definitive guidelines problematic as significant changes in the management of vulval cancer and changes in obstetrical and neonatal care need to be accounted for. Longer-term maternal and neonatal outcomes are also difficult to substantiate. Centralised data collection would be beneficial in these rare tumours, and in other malignant tumours diagnosed and treated during pregnancy. KeywordsVulval/vulvar carcin...

show abstract

“…The patients' age range at presentation was 17-41 years (mean 30 years) (Table 1). The majority of cases was diagnosed in the United States (15 cases) [18,23,27,[29][30][31][35][36][37]40,41], 12 in Europe (5 United Kingdom, 3 France, 2 Germany, 1 Belgium, 1 Holland) [11][12][13]17,20,22,24,26,33,38,39], 6 in Asia (1 Iran, 1 Nepal, 1 Turkey, 1 Malaysia, 1 Saudi Arabia) [14,16,19,21,32,34], 2 in Australia [28] and 2 in Africa (1 Congo, 1 Nigeria) [15,25]. Eight patients were black [15,25,27,29,31,36,41], 6 were white/Caucasian [13,17,22,30,31,40], and 6 were of different Asian races [14,16,21,…”

Section: Age and Racementioning

confidence: 99%

How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature

Palicelli

Giaccherini

Zanelli

et al. 2021

Cancers

View full text Add to dashboard Cite

According to our systematic literature review (PRISMA guidelines), only 37 vulvar squamous cell carcinomas (VSCCs) were diagnosed during pregnancy (age range: 17–41 years). The tumor size range was 0.3–15 cm. The treatment was performed after (14/37, 38%), before (10/37, 27%), or before-and-after delivery (11/37, 30%). We found that 21/37 (57%) cases were stage I, 2 II (5%), 11 III (30%), and 3 IVB (8%). HPV-related features (condylomas/warts; HPV infection; high-grade squamous intraepithelial lesion) were reported in 11/37 (30%) cases. We also found that 9/37 (24%) patients had inflammatory conditions (lichen sclerosus/planus, psoriasis, chronic dermatitis). The time-to-recurrence/progression (12/37, 32%) ranged from 0 to 36 (mean 9) months. Eight women died of disease (22%) 2.5–48 months after diagnosis, 2 (5%) were alive with disease, and 23 (62%) were disease-free at the end of follow-up. Pregnant patients must be followed-up. Even if they are small, newly arising vulvar lesions should be biopsied, especially in women with risk factors (HPV, dermatosis, etc.). The treatment of VSCCs diagnosed in late third trimester might be delayed until postpartum. Elective cesarean section may prevent vulvar wound dehiscence. In the few reported cases, pregnancy/fetal outcomes seemed to not be affected by invasive treatments during pregnancy. However, clinicians must be careful; larger cohorts should define the best treatment. Definite guidelines are lacking, so a multidisciplinary approach and discussion with patients are mandatory.

show abstract

Vulvar Carcinoma Presenting during Pregnancy, Associated with Recurrent Bone Marrow Hypoplasia: A Case Report and Literature Review

Cited by 24 publications

References 7 publications

Carcinoma of the vulva in pregnancy

Carcinoma of the vulva in pregnancy

Squamous Cell Vulval Carcinoma and Pregnancy — A Review

How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature

Contact Info

Product

Resources

About